摘要
目的:分析抗激护肠方治疗腹泻型肠易激综合征(IBS-D)患者的临床治疗效果。方法:选取80例IBS-D患者,随机分为两组。对照组口服匹维溴铵片,观察组口服抗激护肠方。观察两组临床疗效,比较两组患者治疗前后中医症候积分、中华生存质量量表(ChQOL)评分以及相关实验室指标:二胺氧化酶(DAO)、D-乳酸(D-LA)、肠脂肪酸结合蛋白(I-FABP)、肿瘤坏死因子-α(TNF-α)、降钙素相关基因肽(CGRP)、白介素-10(IL-10)、神经肽Y(NPY)。结果:观察组临床有效率明显高于对照组(P<0.05)。治疗后,对照组患者的大便频次、性状、腹痛积分与本组治疗前比较均下降(P<0.05),但总积分比较差异无统计学意义(P>0.05);观察组各项积分及总积分较治疗前均显著降低,差异有统计学意义(P<0.05),且观察组积分与对照组比较明显下降,差异有统计学意义(P<0.05)。治疗后,两组患者相关实验室指标分别优于各组治疗前,且观察组各指标明显优于对照组(P<0.05)。对照组治疗后ChQOL评分与治疗前比较,差异无统计学意义(P>0.05);观察组治疗后ChQOL评分较治疗前提高,差异有统计学意义(P<0.05),且治疗后观察组评分与对照组比较明显升高,差异有统计学意义(P<0.05)。观察组与对照组不良反应发生例数比较差异有统计学意义(P<0.05)。结论:抗激护肠方能明显减轻IBS-D患者临床症状,其机制可能与修复肠黏膜、减轻炎性反应、调控脑-肠轴功能有关。
Objective:To analyze the clinical therapeutic effect of Kangji Huchang formula on patients with diarrhea type irritable bowel syndrome.Methods:Eighty patients with diarrhea irritable bowel syndrome were randomly divided into two groups.The control group was treated the pinaverium bromide tablets orally,while the observation group was orally treated with the Kangji Huchang formula.After treatment,observe the curative effect,and compare the TCM syndrome score,Chinese Quality of Life Scale(ChQOL)score,diamine oxidase(DAO),D-lactic acid(D-LA),intestinal fatty acid binding protein(I-FABP),and tumor necrosis factor(TNF)of the two groups of patients before and after treatment-α(TNF-α)、content of calcitonin related gene peptide(CGRP),interleukin 10(IL-10),and neuropeptide Y(NPY).Results:The effective rate of observation group was higher than that of control group(P<0.05).After treatment,the stool frequency,characteristics,and abdominal pain scores of patients in the control group decreased compared with those before treatment in this group(P<0.05).However,there was no statistically significant difference in total score between the control group before and after treatment(P>0.05).In the observation group,the sub scores and total score of traditional Chinese medicine symptoms were significantly reduced compared to before treatment(P<0.05).The traditional Chinese medicine symptoms scores in the observation group decreased significantly compared to the control group,with a statistical difference(P<0.05).After treatment,the relevant laboratory indexes of the two groups were better than those before treatment,and the indexes of observation group were significantly better than those of control group(P<0.05).There was no statistically significant difference in the quality score of the Chinese Quality of Life Scale(ChQOL)between the control group after treatment and before treatment(P>0.05).The ChQOL score of the observation group after treatment improved compared to before treatment(P<0.05).And there was a significant increase in the score of the observation group compared to the control group after treatment(P<0.05).During the treatment period,the number of adverse reactions in the observation group and control group was statistical differences between the two groups(P<0.05).Conclusion:Kangji Huchang formula can significantly alleviate various discomfort symptoms in patients,with significant clinical efficacy.It’s mechanism may be related to repairing intestinal mucosa,reducing inflammatory reactions,and regulating the function of the brain intestinal axis.
作者
安琦
芦希艳
王伟
安荣
冯军强
AN Qi;LU Xiyan;WANG Wei;AN Rong;FENG Junqiang(Tangdu Hospital of Air Force Medical University,Xi’an 710038,China)
出处
《陕西中医》
CAS
2023年第10期1382-1386,共5页
Shaanxi Journal of Traditional Chinese Medicine
基金
国家自然科学基金资助项目(81873233)
陕西省中医药管理局中医药科研项目(15-JC004)。
关键词
肠易激综合征
腹泻型
抗激护肠方
匹维溴铵
肠黏膜屏障
炎性因子
脑肠肽
Irritable bowel syndrome
Diarrhea type
Kangji Huchang formula
Pinaverium bromide
Intestinal mucosal barrier
Inflammatory factors
Brain-gut peptide